insights_auto
Why is DHER34 up 2,35%?
Dive Deeperchevron_right
DHER34:BVMF
Danaher Corporation Bdr
R$40,44
arrow_upward
+2,35%(+0,93) 1D
6 ຕ.ລ., 17 ໂມງ 8 ນາທີ 00 ວິນາທີ GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHER34...
Open
R$38,71
High
R$40,44
Low
R$38,24
Mkt. cap
146,67 ຕື້
Avg. vol.
2,39 ພັນ
Volume
0,00
52-wk high
R$45,87
52-wk low
R$27,94
Shares outstanding
702,99 ລ້ານ
No. of employees
59 ພັນ
Open
R$38,71
High
R$40,44
Low
R$38,24
Mkt. cap
146,67 ຕື້
Avg. vol.
2,39 ພັນ
Volume
0,00
52-wk high
R$45,87
52-wk low
R$27,94
Shares outstanding
702,99 ລ້ານ
No. of employees
59 ພັນ
News stories
From web sources and news partners
Investing.com Canada
·
51 ນາທີກ່ອນ
Danaher plans AI-powered autonomous lab for antibody research By Investing.com
Stock Titan
·
1 ຊົ່ວໂມງກ່ອນ
A planned lab could make up to 10 times as many research tools each year as it scales.
MarketWatch
·
15 ຊົ່ວໂມງກ່ອນ
Danaher Corp. stock outperforms competitors despite losses on the day
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr